Key Takeaways WTRG reports Q4 EPS of 47 cents, beating estimates, as revenues jump 15.7% year over year. Essential Utilities' water and gas segments post 8% and 23% revenue gains on higher rates and volumes. WTRG advances its merger with American Water Works; shareholders approve deal set to close by Q1'27. Essential Utilities Inc. (WTRG) reported fourth-quarter 2025 operating earnings per share (EPS) of 47 cents, which beat the Zacks Consensus Estimate of 36 cents by 30.56%. The bottom line decreased 29.85 ...

Core Insights - Domino's Pizza, Inc. (DPZ) reported fourth-quarter fiscal 2025 results with earnings missing the Zacks Consensus Estimate but increasing year-over-year, while total revenues surpassed estimates and also increased from the prior year [1][4][10] Financial Performance - Adjusted earnings per share (EPS) for the fourth quarter were $5.35, missing the consensus estimate of $5.38, but up 9.4% from $4.89 in the same quarter last year [4] - Total revenues reached $1,535.7 million, exceeding the consensus mark of $1,516 million, and increased by 6.4% year-over-year [4][10] - Global retail sales (excluding foreign currency impact) rose 4.9% year-over-year, driven by a 5.5% increase in U.S. store sales and a 4.5% increase in international store sales [6] Operational Highlights - The company achieved 392 net store openings during the fourth quarter, contributing to its global expansion [5][10] - Comps at domestic stores increased by 3.7% year-over-year, while international store comps rose by 0.7% [6][8] Margin Analysis - Gross margin expanded by 50 basis points year-over-year to 39.7%, although the gross margin for U.S. company-owned stores contracted by 540 basis points to 10.1% due to rising costs [9][10] Balance Sheet and Capital Management - As of December 28, 2025, cash and cash equivalents totaled $125.7 million, down from $186.1 million a year earlier, while long-term debt increased to $4.81 billion from $3.83 billion [11] - Capital expenditure for the quarter was $120.6 million, up from $112.9 million in the prior year, and the company repurchased 188,526 shares for $80 million [12] Annual Performance - For fiscal 2025, total revenues were $4.94 billion, up from $4.71 billion in 2024, and net income increased to $601.7 million from $584.2 million [13]

Core Insights - The furniture retailer reported better-than-expected sales and adjusted earnings, indicating strong performance in the market [1] - However, a debt extinguishment loss negatively impacted overall profits, highlighting potential financial challenges [1] Sales Performance - The company achieved sales figures that exceeded market expectations, suggesting robust demand for its products [1] - Adjusted earnings also surpassed forecasts, reflecting effective cost management and operational efficiency [1] Financial Impact - The debt extinguishment loss has been a significant factor affecting the company's profitability, which may raise concerns among investors regarding future financial stability [1]

Core Insights - STERIS plc reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.53, reflecting a 9% increase year-over-year, matching the Zacks Consensus Estimate [2][9] - The company's GAAP EPS was $1.96, up 12% from $1.75 in the previous year [2] Revenue Performance - Total revenues from continuing operations reached $1.50 billion, marking a 9.5% year-over-year increase and surpassing the Zacks Consensus Estimate by 1.1% [3][9] - Organic revenues at constant exchange rate (CER) rose by 8% year-over-year [3] - Revenue breakdown by segment: - Healthcare segment revenues increased by 9% to $1.10 billion, with service revenues up 11%, consumable revenues up 8%, and capital equipment revenues up 7% [4] - Applied Sterilization Technologies (AST) revenues improved by 11% to $286.6 million, driven by 9% growth in service revenues and a significant 103% increase in capital equipment revenues [5] - Life Sciences segment revenues rose by 7% to $145.8 million, with consumable revenues up 11% and capital equipment revenues up 7% [6] Margin Analysis - Gross profit for the quarter was $655.5 million, a 7.4% increase from the prior year, but gross margin contracted by 72 basis points to 43.8% due to a 10.6% rise in the cost of revenues [7] - Selling, general and administrative expenses rose by 5% to $352.3 million, while research and development expenses increased by 7.7% to $29.5 million [8] Financial Guidance - STERIS maintained its fiscal 2026 guidance, expecting revenue growth of approximately 8-9% and adjusted EPS in the range of $10.15-$10.30 [11] - The Zacks Consensus Estimate for revenues is $5.93 billion, implying an 8.6% growth from fiscal 2025 [11] Overall Assessment - The company ended the third quarter on a mixed note, with earnings meeting estimates and revenues exceeding expectations, while all business segments experienced growth [12] - Despite increased costs impacting gross margins, the expansion of operating margins is viewed positively for the stock [12]

Core Insights - Boston Scientific Corporation (BSX) reported fourth-quarter 2025 adjusted earnings per share (EPS) of 80 cents, a 14.3% increase from the previous year, surpassing the Zacks Consensus Estimate by 2.6% and exceeding the company's guidance of 77-79 cents [1][2] - The company's full-year adjusted EPS reached $3.06, marking a 21.9% increase from 2024, also exceeding the Zacks Consensus Estimate by 0.7% and the 2025 guidance range of $3.02-$3.04 [2] Revenue Performance - Fourth-quarter revenues totaled $5.29 billion, reflecting a 15.9% year-over-year increase on a reported basis and 14.3% on an operational basis, with organic growth of 12.7% [3] - For the full year 2025, revenues were $20.07 billion, up 19.9% on a reported basis, 19.2% operationally, and 15.8% organically compared to 2024 [4] Regional Revenue Breakdown - In Q4, revenues increased by 17% in the United States, 12.4% in Europe, the Middle East and Africa (EMEA), 15.2% in the Asia Pacific, and 15.9% in Latin America and Canada [5] Segment Performance - MedSurg revenues in Q4 were $1.81 billion, up 15.9% year over year, with Endoscopy generating $760 million (8.2% organic growth) and Urology revenues at $717 million (3.2% organic growth) [7] - The Cardiovascular segment generated $3.48 billion in Q4 revenues, an 18.2% increase reported and 16.1% organically year over year [10] Margin Analysis - The gross margin expanded by 172 basis points to 69.6%, while adjusted operating margin increased by 180 basis points to 24% despite rising costs [11] Future Outlook - For 2026, Boston Scientific anticipates net sales growth of approximately 10.5-11.5% on a reported basis and 10-11% organically, with adjusted EPS expected in the range of $3.43-$3.49 [12] - Q1 2026 revenue growth is projected at 10.5-12% on a reported basis and 8.5-10% organically, with adjusted earnings expected between 78-80 cents per share [13] Strategic Developments - The company achieved broad regulatory approvals and clinical milestones across various franchises, including strategic acquisitions to enhance its vascular and neuromodulation portfolio [15]

S&P 500 oilfield service giant SLB (SLB) reported early Friday better-than-expected fourth-quarter earnings and revenue while also increasing its quarterly dividend and telling investors business headwinds are in the rearview mirror. SLB, formerly known as Schlumberger, saw Q4 EPS fall 15.2% to 78 cents with sales totaling $9.75 billion, up 5.1% vs. a year ago. Prior to Friday's, earnings release,… ...

Group 1 - U.S. stocks experienced an upward trend, with the Dow Jones increasing by approximately 200 points on Thursday [1] - Eagle Bancorp, Inc. reported fourth-quarter earnings of 25 cents per share, surpassing the analyst consensus estimate of a loss of 10 cents per share [1] - The company's quarterly sales reached $68.303 million, exceeding the analyst consensus estimate of $67.033 million [1] Group 2 - Eagle Bancorp shares surged by 19.8% to $28.80 on Thursday [2] - Rich Sparkle Holdings Limited saw a significant increase of 44.7% to $99.96 [3] - Regencell Bioscience Holdings Limited's shares rose by 37.6% to $30.15 [3] - New Era Energy & Digital, Inc. experienced a rise of 31.6% to $9.02 [3] - Corcept Therapeutics Incorporated climbed 17.6% to $42.70 following positive Phase 3 trial results [3] - USA Rare Earth, Inc. gained 17.5% to $22.72 [3] - LSI Industries Inc. rose 15.7% to $23.59 after reporting strong quarterly earnings [3] - NVE Corporation's shares increased by 15.7% to $79.20 following third-quarter results [3] - Sasol Limited's shares jumped 12.7% to $7.11 after raising its six-month performance fuel sales guidance for FY25 [3] - Terrestrial Energy Inc. rose 12.1% to $11.93 [3] - Arista Networks, Inc. gained 10.6% to $140.86 [3] - GRAIL, Inc. saw an increase of 10% to $111.20 [3] - Lemonade, Inc. shares jumped 8.4% to $92.55 [3] - Iridium Communications Inc. gained 8% to $21.19 [3] - Moderna, Inc. increased by 7.3% to $53.43 [3] - Alibaba Group Holding Limited rose 6.6% to $179.81 amid reports of moving towards an IPO for its AI chipmaking unit [3] - Datadog, Inc. shares rose 5.9% to $130.79 after an upgrade from Stifel [3]

Core Viewpoint - G-III Apparel Group Ltd reported better-than-expected third-quarter adjusted EPS results and raised its FY26 adjusted EPS guidance despite facing challenges in the consumer environment and tariff-related margin pressures [1][2]. Financial Performance - The company reported third-quarter adjusted earnings per share of $1.90, exceeding the analyst consensus estimate of $1.61 [1]. - Quarterly sales amounted to $988.649 million, which is a 9% decrease year over year and fell short of the expected $1.012 billion [1]. Guidance Update - G-III Apparel raised its fiscal 2026 adjusted EPS guidance from a range of $2.55-$2.75 to $2.80-$2.90, compared to the previous estimate of $2.68 [4]. - The company lowered its fiscal 2026 sales guidance from $3.020 billion to $2.980 billion, aligning with the previous estimate of $3.020 billion [4]. Market Reaction - Following the earnings announcement, G-III Apparel shares increased by 1.8%, trading at $31.36 [4]. - Analysts adjusted their price targets for G-III Apparel, with Telsey Advisory Group raising it from $30 to $34, Keybanc from $33 to $35, and UBS from $28 to $32 [5]. Tariff Impact - The company anticipates tariffs to have a gross impact of approximately $135 million, which will be partially offset by supplier support, sourcing changes, and selective price increases, resulting in a net unmitigated impact of about $65 million factored into the guidance [3].

Core Insights - Boston Partners increased its stake in Matrix Service Company by 71.5% in Q2, owning 844,966 shares valued at approximately $11.42 million [2] - Other institutional investors also raised their positions, with American Century Companies increasing by 24.1%, Azarias Capital Management by 9.9%, and CenterBook Partners by 789.6% [3] - Institutional investors collectively own 78.38% of Matrix Service's stock [3] Financial Performance - Matrix Service reported a quarterly revenue of $211.88 million, exceeding analysts' expectations of $206.66 million [5] - The company had an EPS of ($0.01), surpassing the consensus estimate of ($0.03) by $0.02 [5] - The firm has set its FY 2026 guidance at EPS, with analysts predicting an EPS of -0.26 for the current fiscal year [5] Stock Performance - Matrix Service's stock opened at $11.69, with a 12-month low of $9.33 and a high of $16.10 [4] - The company has a market capitalization of $328.78 million, a P/E ratio of -11.13, and a PEG ratio of 1.23 [4] Analyst Ratings - DA Davidson maintains a "buy" rating with a price target of $17.00, while Weiss Ratings has a "sell (d-)" rating [7] - The average rating for Matrix Service is "Hold" with a consensus target price of $17.00 [7] Insider Activity - Director John D. Chandler acquired 2,300 shares at an average cost of $12.74, increasing his ownership by 3.04% [6] - Insider Shawn P. Payne sold 8,250 shares at an average price of $12.58, representing a 6.95% decrease in his position [6] - Company insiders own 4.40% of the stock [6] Company Overview - Matrix Service Company provides engineering, fabrication, construction, and maintenance services for energy infrastructure and industrial markets [9] - The company operates through three segments: Utility and Power Infrastructure, Process and Industrial Facilities, and Storage and Terminal Solutions [9]

Core Insights - Kohl's reported revenue of $3.58 billion for the quarter ended October 2025, reflecting a year-over-year decline of 3.6% and an EPS of $0.10 compared to $0.20 a year ago, with a revenue surprise of +2.55% over the Zacks Consensus Estimate of $3.49 billion and an EPS surprise of +152.63% over the consensus estimate of -$0.19 [1] Financial Performance - The total number of stores remained at 1,153, matching the four-analyst average estimate [4] - Comparable store sales showed a year-over-year change of -1.7%, better than the -4.2% estimated by four analysts [4] - Net sales were reported at $3.41 billion, exceeding the four-analyst average estimate of $3.32 billion, with a year-over-year change of -2.9% [4] - Other revenue was reported at $168 million, slightly above the four-analyst average estimate of $166.82 million, with a year-over-year decline of 17.2% [4] Stock Performance - Kohl's shares have returned -3.9% over the past month, compared to the Zacks S&P 500 composite's -1.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]